Patent details

Basic Information

Publication number:

EP2989125

PCT Application Number:

EP2014057909

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147181150

PCT Publication Number:

WO2014173814

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST

French Title of Invention:

POLYTHÉRAPIE À BASE DÝANTICORPS CONTRE L'AGONISTE TLR9 ET CSF-1R HUMAIN

German Title of Invention:

KOMBINATIONSTHERAPIE VON ANTIKÖRPER GEGEN MENSCHLICHE CSF-1R- UND TLR9-AGONISTEN

SPC Number:

Dates

Filing date:

17/04/2014

Grant date:

11/09/2019

EP Publication Date:

02/03/2016

PCT Publication Date:

30/10/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/09/2019

EP B1 Publication Date:

11/09/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/04/2020

Expiration date:

17/04/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/09/2019

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

RIES, Carola

Address:

Germany (DE)

2

Name:

WARTHA, Katharina

Address:

Switzerland (CH)

3

Name:

HOVES, Sabine

Address:

Germany (DE)

4

Name:

RUETTINGER, Dominik

Address:

Germany (DE)

Priority

Priority Number:

13164695

Priority Date:

22/04/2013

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61P 35/00;

Publication

European Patent Bulletin

Issue number:

201937

Publication date:

11/09/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages